Analysis of the KRAS gene showed only a G12C variation in one large cell carcinoma (LCC) patient, whereas variants were not found in adenocarcinoma (ADC) and squamous cell carcinoma (SCC) cases. This evidence concerns the gene KRAS and leukoencephalopathy with calcifications and cysts.